• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVE DIVISION MOSAIC MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVE DIVISION MOSAIC MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 310C29
Device Problems Perivalvular Leak (1457); Incomplete Coaptation (2507)
Patient Problem No Code Available (3191)
Event Date 06/02/2019
Event Type  Injury  
Manufacturer Narrative
Product analysis: no product was returned.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that this 29mm mitral bioprosthetic valve was implanted and explanted during the same procedure.After implant, an echocardiogram was performed which indicated an immobile leaflet along with "leaking".The device was explanted and then replaced with 27mm mitral bioprosthetic valve.No additional adverse patient effects were reported. .
 
Manufacturer Narrative
Product analysis: upon receipt at medtronic¿s quality laboratory, visual examination revealed that the valve was discolored showing evidence of blood contact.One green multifilament suture remained attached to the sewing ring adjacent to non-coronary (nc) cusp.There were small needle holes on the sewing ring indicative of implantation sutures.There was marginal damage on the sewing ring, attributed to explant.All leaflets are in a semi-relaxed position which is a standard finding for this valve as it is processed with the leaflets in relaxed state.Due to the leaflets¿ stiff receipt condition, full closure of the free margins was restricted.As received, the valve does not reflect normal conditions; therefore, no further functional testing can be performed.All leaflets were slightly stiff but flexible and were thickened and slightly desiccated.All commissures were intact.Conclusion: the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.Based on the available information, the cause of one leaflet being immobile and regurgitation could not be determined.There were no issues of leaflets defects identified in the dhr review that would contribute to an immobile leaflet.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC MITRAL BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVE DIVISION
1851 e deere ave
santa ana CA 92705
MDR Report Key8682673
MDR Text Key147457190
Report Number2025587-2019-01868
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 11/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/24/2023
Device Model Number310C29
Device Catalogue Number310C29
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/05/2019
Initial Date Manufacturer Received 06/02/2019
Initial Date FDA Received06/10/2019
Supplement Dates Manufacturer Received11/05/2019
Supplement Dates FDA Received11/22/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
-
-